全文获取类型
收费全文 | 2982篇 |
免费 | 278篇 |
出版年
2022年 | 9篇 |
2021年 | 40篇 |
2020年 | 27篇 |
2019年 | 20篇 |
2018年 | 36篇 |
2017年 | 27篇 |
2016年 | 61篇 |
2015年 | 100篇 |
2014年 | 107篇 |
2013年 | 134篇 |
2012年 | 177篇 |
2011年 | 198篇 |
2010年 | 144篇 |
2009年 | 128篇 |
2008年 | 199篇 |
2007年 | 187篇 |
2006年 | 201篇 |
2005年 | 152篇 |
2004年 | 172篇 |
2003年 | 163篇 |
2002年 | 166篇 |
2001年 | 37篇 |
2000年 | 35篇 |
1999年 | 41篇 |
1998年 | 41篇 |
1997年 | 50篇 |
1996年 | 41篇 |
1995年 | 44篇 |
1994年 | 30篇 |
1993年 | 22篇 |
1992年 | 31篇 |
1991年 | 26篇 |
1990年 | 26篇 |
1989年 | 34篇 |
1988年 | 35篇 |
1987年 | 19篇 |
1986年 | 17篇 |
1985年 | 18篇 |
1984年 | 28篇 |
1983年 | 16篇 |
1982年 | 23篇 |
1981年 | 21篇 |
1980年 | 17篇 |
1979年 | 21篇 |
1978年 | 12篇 |
1977年 | 9篇 |
1976年 | 10篇 |
1975年 | 15篇 |
1969年 | 9篇 |
1968年 | 6篇 |
排序方式: 共有3260条查询结果,搜索用时 15 毫秒
991.
Chiara Rancan Leah Schirrmann Corinna Hüls Reinhard Zeidler Andreas Moosmann 《PLoS pathogens》2015,11(6)
The common pathogen Epstein-Barr virus (EBV) transforms normal human B cells and can cause cancer. Latent membrane protein 2A (LMP2A) of EBV supports activation and proliferation of infected B cells and is expressed in many types of EBV-associated cancer. It is not clear how latent EBV infection and cancer escape elimination by host immunity, and it is unknown whether LMP2A can influence the interaction of EBV-infected cells with the immune system. We infected primary B cells with EBV deleted for LMP2A, and established lymphoblastoid cell lines (LCLs). We found that CD8+ T cell clones showed higher reactivity against LMP2A-deficient LCLs compared to LCLs infected with complete EBV. We identified several potential mediators of this immunomodulatory effect. In the absence of LMP2A, expression of some EBV latent antigens was elevated, and cell surface expression of MHC class I was marginally increased. LMP2A-deficient LCLs produced lower amounts of IL-10, although this did not directly affect CD8+ T cell recognition. Deletion of LMP2A led to several changes in the cell surface immunophenotype of LCLs. Specifically, the agonistic NKG2D ligands MICA and ULBP4 were increased. Blocking experiments showed that NKG2D activation contributed to LCL recognition by CD8+ T cell clones. Our results demonstrate that LMP2A reduces the reactivity of CD8+ T cells against EBV-infected cells, and we identify several relevant mechanisms. 相似文献
992.
André Fischer Nils Enkler Gerd Neudert Marco Bocola Reinhard Sterner Rainer Merkl 《BMC bioinformatics》2009,10(1):54
Background
Computational enzyme design is far from being applicable for the general case. Due to computational complexity and limited knowledge of the structure-function interplay, heuristic methods have to be used. 相似文献993.
994.
995.
Agata Witkowska Susann Spindler Reza Gholami Mahmoodabadi Vahid Sandoghdar Reinhard Jahn 《Biophysical journal》2020,119(12):2431
Fusion of biological membranes, although mediated by divergent proteins, is believed to follow a common pathway. It proceeds through distinct steps, including docking, merger of proximal leaflets (stalk formation), and formation of a fusion pore. However, the structure of these intermediates is difficult to study because of their short lifetime. Previously, we observed a loosely and tightly docked state preceding leaflet merger using arresting point mutations in SNARE proteins, but the nature of these states remained elusive. Here, we used interferometric scattering (iSCAT) microscopy to monitor diffusion of single vesicles across the surface of giant unilamellar vesicles (GUVs). We observed that the diffusion coefficients of arrested vesicles decreased during progression through the intermediate states. Modeling allowed for predicting the number of tethering SNARE complexes upon loose docking and the size of the interacting membrane patches upon tight docking. These results shed new light on the nature of membrane-membrane interactions immediately before fusion. 相似文献
996.
997.
998.
999.
Bettina Huber Christina Schellenbacher Christoph Jindra Dieter Fink Saeed Shafti-Keramat Reinhard Kirnbauer 《PloS one》2015,10(3)
Persistent infection with oncogenic human papillomaviruses (HPV) types causes all cervical and a subset of other anogenital and oropharyngeal carcinomas. Four high-risk (hr) mucosal types HPV16, 18, 45, or 59 cause almost all cervical adenocarcinomas (AC), a subset of cervical cancer (CxC). Although the incidence of cervical squamous cell carcinoma (SCC) has dramatically decreased following introduction of Papanicolaou (PAP) screening, the proportion of AC has relatively increased. Cervical SCC arise mainly from the ectocervix, whereas AC originate primarily from the endocervical canal, which is less accessible to obtain viable PAP smears. Licensed (bivalent and quadrivalent) HPV vaccines comprise virus-like particles (VLP) of the most important hr HPV16 and 18, self-assembled from the major capsid protein L1. Due to mainly type-restricted efficacy, both vaccines do not target 13 additional hr mucosal types causing 30% of CxC. The papillomavirus genus alpha species 7 (α7) includes a group of hr types of which HPV18, 45, 59 are proportionally overrepresented in cervical AC and only partially (HPV18) targeted by current vaccines. To target these types, we generated a chimeric vaccine antigen that consists of a cross-neutralizing epitope (homologue of HPV16 RG1) of the L2 minor capsid protein of HPV45 genetically inserted into a surface loop of HPV18 L1 VLP (18L1-45RG1). Vaccination of NZW rabbits with 18L1-45RG1 VLP plus alum-MPL adjuvant induced high-titer neutralizing antibodies against homologous HPV18, that cross-neutralized non-cognate hr α7 types HPV39, 45, 68, but not HPV59, and low risk HPV70 in vitro, and induced a robust L1-specific cellular immune response. Passive immunization protected mice against experimental vaginal challenge with pseudovirions of HPV18, 39, 45 and 68, but not HPV59 or the distantly related α9 type HPV16. 18L1-45RG1 VLP might be combined with our previously described 16L1-16RG1 VLP to develop a second generation bivalent vaccine with extended spectrum against hr HPV. 相似文献
1000.